None listed
Conditions
Brief summary
The purpose of this study is to assess if melanoma prevention behaviours can be improved by providing individuals with personalised melanoma risk information and prevention recommendations based on their level of risk. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have the capacity to give informed consent in English. Study details Participants in this study will be randomly (by chance) allocated to one of two groups. Participants in both groups will receive general prevention information on melanoma. One group will then additionally receive personalised melanoma risk information and prevention recommendations based on their risk levels. Risk levels will be based on self-assessed melanoma information. Participants will be assessed on melanoma risk perceptions, melanoma risk reduction intentions and melanoma prevention behaviours 6 and 12 weeks after the intervention by follow up questionnaire. This research will help determine if providing individual melanoma risk information improves melanoma prevention behaviours in healthy adults.
Interventions
All participants will complete a self-administered baseline questionnaire presented as a secure web-based application on a mobile small screen tablet, unassisted, in the general practice waiting room and receive general prevention information on melanoma- this will include information on what is melanoma, melanoma risk factors, primary and secondary prevention measures, and how to balance sun protection with the vitamin D levels. We anticipate the questionnaire will take approximately 5 to 10 mi
All participants will complete a self-administered baseline questionnaire presented as a secure web-based application on a mobile small screen tablet, unassisted, in the general practice waiting room and receive general prevention information on melanoma- this will include information on what is melanoma, melanoma risk factors, primary and secondary prevention measures, and how to balance sun protection with the vitamin D levels. We anticipate the questionnaire will take approximately 5 to 10 minutes to complete. Additionally, intervention group participants will receive personalised melanoma risk information and prevention recommendations based on their risk levels. The personalised melanoma risk information and prevention recommendations will be based on the participant's self-assessed melanoma risk factors from the baseline questionnaire, and presented to the participant on the secure web-based application on a mobile small screen tablet which will also be printed out.
Sponsors
Sydney School of Public Health, Sydney Medical School, University of Sydney
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
To be eligible a patient must be aged over 18 years, have the capacity to give informed consent in English to answer the study questions.
Exclusion criteria
Patients with a current or previous history of melanoma will be excluded.
Outcome results
None listed